Skip to content

Bill Schiffner

For American patients to be put first, DIR fee relief is essential

The following was a post Monday from NACDS president and chief executive officer Steven Anderson on Medium urging action on DIR fee relief in final Medicare rule: We may be just days from learning whether a pending Medicare rule will provide relief from pharmacy direct and indirect remuneration (DIR

How to get out from the suffocating miasma of DIR fees

The direct and indirect remuneration (DIR) component of Medicare Part D programs today is very complicated and has been implemented in a variety of ways. The lack of clarity, fairness and transparency to all parties has created business challenges for pharmacies.

Consumers embrace new healthy living mindsets

It’s hard to miss the heightened shopper interest in health and wellness these days. In our recent “How America Shops” study, The Big Business of WELL, many shoppers showed they are committed to being well: 42% said that while it costs more to “live healthy,” it’s worth it.

Sera Labs: a thriving CBD company with a difference

The retail market for products containing CBD is projected to expand rapidly in the coming years amid the growing acceptance of hemp and cannabis across the country. One of the up-and-coming companies in this category is Sera Labs.

CBD’s place in the chain drug merchandise mix

Two thousand eighteen may be remembered in retail marketing history as the year discussing CBD moved from Bon-naroo to the board room.  Extensive media coverage; legalization of all forms of cannabis in Canada and parts of the U.S.

A retailer at heart should lead Rite Aid

A new phase in Rite Aid’s two-decade-long quest to fully recover from the criminal financial irregularities that pushed it to the brink of bankruptcy in the late 1990s began last month with top-level management changes and an organizational realignment designed to, in the words of Bruce Bodaken, cha